Clinical trials
Completed Precursor Cell Lymphoblastic Leukemia-Lymphoma trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
78 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 2 |
| 2002 | 2 |
| 2003 | 7 |
| 2004 | 6 |
| 2005 | 5 |
| 2006 | 2 |
| 2007 | 3 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 5 |
| 2011 | 3 |
| 2012 | 5 |
| 2013 | 5 |
| 2014 | 3 |
| 2015 | 3 |
| 2016 | 2 |
| 2017 | 4 |
| 2018 | 1 |
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 78 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Goethe University | 13 |
| Fred Hutchinson Cancer Center | 8 |
| Novartis Pharmaceuticals | 7 |
| Amgen | 5 |
| Amgen Research (Munich) GmbH | 5 |
| European Organisation for Research and Treatment of Cancer - EORTC | 5 |
| Charite University, Berlin, Germany | 3 |
| Kiadis Pharma | 3 |
| Universitätsklinikum Hamburg-Eppendorf | 3 |
| Bristol-Myers Squibb | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 78 |
| Leukemia, Myeloid, Acute | 24 |
| Lymphoma, Non-Hodgkin | 16 |
| Recurrence | 16 |
| Burkitt Lymphoma | 15 |
| Leukemia | 14 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 14 |
| Hodgkin Disease | 13 |
| Multiple Myeloma | 13 |
| Lymphoma, Follicular | 12 |
Trials
Showing 1 to 25 of 78. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.